Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Spending on GLP-1 drugs continues to rise, after outpacing trends among specialty drugs for the first time in 2023, according ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

In this article, you can learn about the rights to brand-name drugs ... Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. It’s approved by the Food and Drug Administration (FDA ...

The list price for GLP-1 drugs in the United States ranges between ... “When I start these brand name medications, part of my consent process for these meds is a discussion with my patients ...

a type of GLP-1 drug, was approved for chronic weight management in 2021, the Evernorth report found. GLP-1s can be quite costly: List prices for GLP-1s Wegovy and Ozempic hover around $1,000 ...

Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment ... of food noise” — that many users of Novo Nordisk’s Ozempic and Wegovy (brand names for semaglutide), as well as Lilly’s ...